Park et al. suggests that in wild-type mice, treatment with neutralizing antibodies against TNF-α, IL-17A or IL-6 has a protective effect on hepatic and small intestine injury because of ischemic or non-ischemic AKI [119]. The gene discussed is IL17A; the disease is acute kidney injury.